DECREASED INTERSTITIAL FOXP3+ LYMPHOCYTES IN USUAL INTERSTITIAL PNEUMONIA WITH DISCREPANCY OF CXCL12/CXCR4 AXIS

被引:29
|
作者
Shimizu, Y. [1 ,2 ]
Dobashi, K. [3 ]
Endou, K. [1 ]
Ono, A. [1 ]
Yanagitani, N. [1 ]
Utsugi, M. [1 ]
Sano, T. [4 ]
Ishizuka, T. [1 ]
Shimizu, K. [5 ]
Tanaka, S. [6 ]
Mori, M. [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan
[2] Dokkyo Univ, WHO, Collaborating Ctr Prevent & Control Chron Resp Di, Mibu, Tochigi, Japan
[3] Gunma Univ, Fac Hlth Sci, Maebashi, Gunma 3718511, Japan
[4] Gunma Univ, Grad Sch Med, Dept Tumor Pathol, Maebashi, Gunma 3718511, Japan
[5] Gunma Univ, Grad Sch Med, Div Thorac & Visceral Organ Surg, Maebashi, Gunma 3718511, Japan
[6] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, Maebashi, Gunma 3718511, Japan
关键词
CXCL12; CXCR4; regulatory T cell; FOXP3; idiopathic pulmonary fibrosis; IDIOPATHIC PULMONARY-FIBROSIS; HUMAN LUNG FIBROBLASTS; REGULATORY T-CELLS; EXPRESSION; FIBROCYTES; DISEASE; MICE;
D O I
10.1177/039463201002300207
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Treg) play a critical role in immune homeostasis and expansion of Treg is controlled by chemokine receptors. The chemokine CXCL12 and its G-protein-coupled receptor (CXCR4) are involved in the development of idiopathic pulmonary fibrosis (IPF), but the association of Treg with the CXCL12/CXCR4 axis has not been documented. The aim of this study is to determine the distribution and extent of CXCL12/CXCR4 expression in idiopathic type of pulmonary fibrosis, and the relation of Treg expansion in the interstitium of pulmonary fibrosis patients to CXCL12/CXCR4 expression. CXCL12 expression was examined by immunostaining and ELISA in tissue specimens from patients with usual interstitial pneumonia (UIP, n=15), patients with fibrotic non-specific interstitial pneumonia (f-NSIP, n=4), and controls (n=6). CXCR4 expression was examined by in situ hybridization and immunoblotting. Expression of CD45, CD3, CD20, transcription factor forkhead box P3 (FOXP3), and CD25 was assessed by immunostaining. Fibrosis was evaluated by determining the established fibrosis (EF) score. The CXCL12/CXCR4 axis was upregulated in UIP and f-NSIP, and CXCL12 derived from lung tissue attracted CXCR4(+) cells. CXCR4(+) cells showed a CD3(+) cell distribution pattern. The interstitial FOXP3(+)/CD3(+) and CD25(+)/CD3(+) cell ratios were lower in UIP than f-NSIP, but the CXCR4(+)/CD3(+) cell ratio was not different. The FOXP3(+)/CD3(+) cell ratio and EF score were inversely correlated. These findings suggest that the CXCL12/CXCR4 axis contributes to inflammation in UIP and f-NSIP by promoting the accumulation CXCR4(+) lymphocytes, and a decrease of Treg is correlated with the severity of fibrosis in UIP.
引用
收藏
页码:449 / 461
页数:13
相关论文
共 50 条
  • [21] The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular disease
    Doering, Yvonne
    Pawig, Lukas
    Weber, Christian
    Noels, Heidi
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [22] Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
    Mao, T. L.
    Fan, K. F.
    Liu, C. L.
    GENE THERAPY, 2017, 24 (10) : 621 - 629
  • [23] Potential of CXCR4/CXCL12 Chemokine Axis in Cancer Drug Delivery
    Wang Y.
    Xie Y.
    Oupický D.
    Current Pharmacology Reports, 2016, 2 (1) : 1 - 10
  • [24] Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
    T L Mao
    K F Fan
    C L Liu
    Gene Therapy, 2017, 24 : 621 - 629
  • [25] Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer
    Yasumoto, K
    Koizumi, K
    Kawashima, A
    Saitoh, Y
    Arita, Y
    Shinohara, K
    Minami, T
    Nakayama, T
    Sakurai, H
    Takahashi, Y
    Yoshie, O
    Saiki, I
    CANCER RESEARCH, 2006, 66 (04) : 2181 - 2187
  • [26] Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors
    Baccalini, Edoardo Andrea
    Renne, Salvatore Lorenzo
    Colombo, Piergiuseppe
    Pasqualini, Fabio
    Quagliuolo, Vittorio Lorenzo
    Cananzi, Ferdinando Carlo Maria
    Grizzi, Fabio
    Borroni, Elena Monica
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (20) : 2248 - 2253
  • [27] Erratum to: CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
    Xueqing Sun
    Guangcun Cheng
    Mingang Hao
    Jianghua Zheng
    Xiaoming Zhou
    Jian Zhang
    Russell S. Taichman
    Kenneth J. Pienta
    Jianhua Wang
    Cancer and Metastasis Reviews, 2011, 30 : 269 - 270
  • [28] Functions of CXCL12 and CXCR4 in breast cancer
    Luker, Kathryn E.
    Luker, Gary D.
    CANCER LETTERS, 2006, 238 (01) : 30 - 41
  • [29] CXCL12 and CXCR4 in bone marrow physiology
    Moll, Natalia M.
    Ransohoff, Richard M.
    EXPERT REVIEW OF HEMATOLOGY, 2010, 3 (03) : 315 - 322
  • [30] CXCL12/SDF-1 and CXCR4
    Nagasawa, Takashi
    FRONTIERS IN IMMUNOLOGY, 2015, 6